March is National Kidney Month – a time to raise awareness and learn more about kidney health and kidney disease. Earlier in ...

As Gen Z college students like myself peruse TikTok and Instagram, we see videos with captions like “Is Kyle Jenner on ...

The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...

Wegovy is also available through NovoCare Pharmacy, which directly ship all dose strengths at a cost of $499 per month for ...

Mounjaro, a weekly injection, targets GIP and GLP-1 hormones to enhance insulin release and appetite regulation, aiding ...

It was only a matter of time until the GLP-1 receptor agonist drugs like Ozempic and Wegovy were superseded, and now it looks ...

Ozempic may worsen your condition. Additionally, there have been reports of acute (sudden) kidney injury and worsening of chronic kidney disease with Ozempic since the drug was made available on ...

Novo Nordisk has signed an exclusive global licensing deal worth up to $2 billion for UBT251, a weight-loss drug developed by ...

CHICAGO -- Coming this weekend, the American College of Cardiology (ACC) annual conference will feature research exploring ...

Currently, there are six FDA approved weight loss medications. They include three GLP-1 receptor agonists -- liraglutide ...

It’s also approved to reduce the risk of cardiovascular events and to manage chronic kidney disease in people with type 2 diabetes. While Ozempic doesn’t come up on standard drug tests ...

Glucagon-like peptide-1 (GLP-1) and Gastric inhibitory polypeptide (GIP) while Ozempic (Semaglutide) only targets GLP-1.